Amyostatic syndrome is a rare genetic disorder that occurs in one in a million cases and is characterized by developmental delay and motor impairment in infants. This condition is a severe disabling pathology that requires a comprehensive interdisciplinary approach to diagnosis and treatment. This syndrome is caused by mutations in the STK25 (serine/threonine kinase) gene